TPSF
NBIX icon

Texas Permanent School Fund’s Neurocrine Biosciences NBIX Stock Holding History

Texas Permanent School Fund’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-87,087
Closed -$12M – 910
2024
Q1 		$12M Buy
87,087
+2,211
+3% +$302K 0.09% 178
2023
Q4 		$11.2M Buy
84,876
+1,941
+2% +$223K 0.1% 170
2023
Q3 		$9.33M Sell
82,935
-2,978
-3% -$314K 0.09% 182
2023
Q2 		$8.1M Sell
85,913
-707
-0.8% -$69.1K 0.08% 239
2023
Q1 		$8.77M Buy
86,620
+21,990
+34% +$2.29M 0.09% 199
2022
Q4 		$7.72M Sell
64,630
-4,155
-6% -$487K 0.12% 147
2022
Q3 		$7.31M Sell
68,785
-296
-0.4% -$30K 0.12% 140
2022
Q2 		$6.73M Buy
69,081
+1,825
+3% +$168K 0.11% 157
2022
Q1 		$6.3M Sell
67,256
-1,140
-2% -$96.6K 0.09% 215
2021
Q4 		$5.83M Sell
68,396
-1,617
-2% -$149K 0.07% 287
2021
Q3 		$6.71M Sell
70,013
-445
-0.6% -$42K 0.08% 221
2021
Q2 		$6.86M Buy
70,458
+278
+0.4% +$26.6K 0.08% 241
2021
Q1 		$6.83M Buy
+70,180
New +$7.36M 0.08% 224

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Texas Permanent School Fund's NBIX Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Neurocrine Biosciences (NBIX) in Q2 2024, closing a stake of 87,087 shares — an estimated $12M sold.

Texas Permanent School Fund first reported a position in NBIX in Q1 2021 and held it in 13 quarters. The position peaked at $12M in Q1 2024. 594 funds tracked by Wall St. Rank hold NBIX as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Neurocrine Biosciences position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 87,087 Neurocrine Biosciences shares in Q2 2024, an estimated $12M.
  • Texas Permanent School Fund first reported a position in Neurocrine Biosciences in Q1 2021 and held it in 13 quarters.
  • Texas Permanent School Fund's Neurocrine Biosciences position peaked at $12M in Q1 2024.
  • 594 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.